I had the pleasure of participating in an Australian expert panel on TACE for HCC. Guebert are the manufacturers of lipiodol which is the poppy seed oil based dye which is used for conventional TACE, especially in Asian countries and Australia. TACE is the treatment of choice for patient with HCC which is not amenable to ablation or resection. Guerbet brought together a group of interventional radiologists with experience in interventional oncology and TACE to discuss issues around the treatment.
It was nice to catch up with colleagues and old friend from interstate and to meet the guest speaker from the USA, Dr Jafar Golzarian, who is also the convenor of GEST (Global Embolization Symposium and Technologies) – embolization meeting. Jafar was very friendly and knowledgable and I was grateful for the opportunity to hear him speak and to meet him and hear his opinions on embolization and interventional radiology in general.